Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma
Our research reveals the prognostic value of disulfidptosis in MM and provides new perspectives for identifying heterogeneity and therapeutic targets.
Authors
- Xudong Hu (ORCID: https://orcid.org/0000-0002-4297-8360)
- Luning Cui
- Sisi Zheng (ORCID: https://orcid.org/0000-0001-9283-4472)
- Yan Zhuang (ORCID: https://orcid.org/0000-0002-6816-3071)
- Xuanru Lin
- Xinyi Zhang
- Songfu Jiang (ORCID: https://orcid.org/0000-0002-1458-1753)
- Shujuan Zhou (ORCID: https://orcid.org/0000-0003-3809-7613)
- Zhouxiang Jin
- Zhili Lin
- Honglan Qian
- Zixing Chen
- Dong Zheng (ORCID: https://orcid.org/0000-0002-8343-3914)
- Hao Ying (ORCID: https://orcid.org/0000-0002-4891-6785)
- Quanqiang Wang
- Yu Zhang (ORCID: https://orcid.org/0000-0003-0869-9429)
- Bingxin Zhang (ORCID: https://orcid.org/0000-0003-2617-0588)
- Qianying Zhang (ORCID: https://orcid.org/0000-0002-8755-9477)
- Shuxia Zhu (ORCID: https://orcid.org/0009-0005-9332-3072)
- Yongyong Ma
- Ziwei Zheng (ORCID: https://orcid.org/0009-0002-8759-5889)
- Qiang Zhuang
- Enqing Lan
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
- Zhejiang Hospital (CN)
- Zhejiang Lab (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1559317
- Citations
- 1
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.81